Jpmorgan Chase & CO Ars Pharmaceuticals, Inc. Comm Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Jpmorgan Chase & CO holds 32,822 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,822
Previous 33,000
0.54%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions